This review highlights bioactive metabolites from yeasts that improve insulin sensitivity in type 2 diabetes, suggesting they may serve as functional agents.
Key Points
Yeast metabolites enhance insulin sensitivity and alleviate inflammation in type 2 diabetes.
Key metabolites include short-chain fatty acids and bioactive peptides, which improve gut health and metabolic responses.
Analysis of yeast metabolites indicates potential to develop effective nutraceuticals for diabetes management.
The findings suggest exploring yeast metabolome can lead to promising functional agents for clinical applications.
Cite This Study
Laverdure Tchamani Piame (2025) studied this question.